BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16413713)

  • 1. Preparation of immuno-stimulating complexes (ISCOMs) by ether injection.
    Pham HL; Shaw PN; Davies NM
    Int J Pharm; 2006 Mar; 310(1-2):196-202. PubMed ID: 16413713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-stimulating complexes prepared by ethanol injection.
    Lendemans DG; Myschik J; Hook S; Rades T
    J Pharm Pharmacol; 2005 Jun; 57(6):729-33. PubMed ID: 15969927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis.
    Demana PH; Davies NM; Berger B; Vosgerau U; Rades T
    J Pharm Pharmacol; 2004 May; 56(5):573-80. PubMed ID: 15142333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Davies NM
    Int J Pharm; 2009 Jul; 376(1-2):123-33. PubMed ID: 19375488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix.
    Liang M; Toth I; Davies NM
    Eur J Pharm Biopharm; 2008 Mar; 68(3):840-5. PubMed ID: 18182279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
    Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
    Demana PH; Davies NM; Hook S; Rades T
    J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method.
    Demana PH; Davies NM; Berger B; Rades T
    Int J Pharm; 2004 Jul; 278(2):263-74. PubMed ID: 15196631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the preparation, microscopic investigation and application of ISCOMs.
    Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
    Micron; 2006; 37(8):724-34. PubMed ID: 16750912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
    Copland MJ; Rades T; Davies NM
    Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
    Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
    Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cage-like complexes formed by DOTAP, Quil-A and cholesterol.
    Lendemans DG; Egert AM; Hook S; Rades T
    Int J Pharm; 2007 Mar; 332(1-2):192-5. PubMed ID: 17049770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic cage-like complexes formed by DC-cholesterol, Quil-A, and phospholipid.
    Lendemans DG; Myschik J; Hook S; Rades T
    J Pharm Sci; 2005 Aug; 94(8):1794-807. PubMed ID: 15986471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Quil A on liposomal membranes.
    Paepenmüller T; Müller-Goymann CC
    Int J Pharm; 2014 Nov; 475(1-2):138-46. PubMed ID: 25107288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
    Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
    Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement of lipids for the formation of immunostimulating complexes (iscoms).
    Lövgren K; Morein B
    Biotechnol Appl Biochem; 1988 Apr; 10(2):161-72. PubMed ID: 2838046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quil A and ISCOMs as adjuvants for midgut membrane antigens of Boophilus microplus.
    Jackson LA; Opdebeeck JP
    Appl Parasitol; 1994 Jun; 35(2):87-98. PubMed ID: 8087157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISCOMs and ISCOMATRIX.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
    Behboudi S; Morein B; Rönnberg B
    Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.